167 results on '"Kobayakawa, Takuya"'
Search Results
2. Design, synthesis and evaluation of bioactivity of peptidomimetics based on chloroalkene dipeptide isosteres
3. Identification of SARS-CoV-2 Mpro inhibitors containing P1’ 4-fluorobenzothiazole moiety highly active against SARS-CoV-2
4. Synthesis and evaluation of DAG-lactone derivatives with HIV-1 latency reversing activity
5. Sensitivity to a CD4 mimic of a consensus clone of monkey-adapted CCR5-tropic SHIV-MK38C
6. Hybrids of small CD4 mimics and gp41-related peptides as dual-target HIV entry inhibitors
7. Potent and biostable inhibitors of the main protease of SARS-CoV-2
8. Exploratory studies on soluble small molecule CD4 mimics as HIV entry inhibitors
9. Effect of Two-Photon Excitation to 8-Azacoumarin Derivatives as Photolabile Protecting Groups
10. Conjugated Compounds Involving Peptides
11. Peptidomimetics That Mimic the Tertiary Structures of Peptides
12. Summary and Future Perspectives of Researches on Mid-size Drugs
13. Conformational-Restricted Cyclic Peptides
14. Peptidomimetics That Mimic the Secondary Structures of Peptides
15. Introduction to Mid-size Drugs and Peptidomimetics
16. Chloroalkene Dipeptide Isosteres as Peptidomimetics
17. Discovery of Potent DAG-Lactone Derivatives as HIV Latency Reversing Agents.
18. Exploratory Studies on Amide Bond Replacement of a SARS-CoV-2 Main Protease Inhibitor Utilizing a Chloroalkene Dipeptide Isostere
19. Chloroalkene dipeptide isosteres as peptidomimetics
20. Structure–Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties
21. Stereoselective synthesis of Xaa-Yaa type (Z)-chloroalkene dipeptide isosteres via efficient utilization of organocopper reagents mediated allylic alkylation
22. Efficient synthesis of Xaa-Gly type (Z)-chloroalkene dipeptide isosteres via organocuprate mediated reduction
23. Conformational-Restricted Cyclic Peptides
24. Mid-size Drugs Based on Peptides and Peptidomimetics
25. Conjugated Compounds Involving Peptides
26. Chloroalkene Dipeptide Isosteres as Peptidomimetics
27. Introduction to Mid-size Drugs and Peptidomimetics
28. Peptidomimetics That Mimic the Tertiary Structures of Peptides
29. Summary and Future Perspectives of Researches on Mid-size Drugs
30. Peptidomimetics That Mimic the Secondary Structures of Peptides
31. Development of anti-HBV agents targeting HBV capsid proteins.
32. Characterization of a Novel CD4 Mimetic Compound YIR-821 against HIV-1 Clinical Isolates
33. Dimerized fusion inhibitor peptides targeting the HR1–HR2 interaction of SARS-CoV-2
34. Low-molecular-weight anti-HIV-1 agents targeting HIV-1 capsid proteins
35. Hybrids of Small CD4 Mimics and Gp41-Related Peptides as Dual-Target HIV Entry Inhibitors
36. Identification of SARS-CoV-2 Mpro inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2.
37. Development of anti-HBV agents targeting HBV capsid proteinsElectronic supplementary information (ESI) available: Experimental procedures including characterization data of novel synthetic compounds. See DOI: https://doi.org/10.1039/d3md00258f
38. Development of Methods for Convergent Synthesis of Chloroalkene Dipeptide Isosteres and Its Application
39. A Therapeutic Strategy to Combat HIV-1 Latently Infected Cells With a Combination of Latency-Reversing Agents Containing DAG-Lactone PKC Activators
40. Small-Molecule Anti-HIV-1 Agents Based on HIV-1 Capsid Proteins
41. Hybrids of Small-Molecule CD4 Mimics with Polyethylene Glycol Units as HIV Entry Inhibitors
42. Fluorescence resonance energy transfer-based screening for protein kinase C ligands using 6-methoxynaphthalene-labeled 1,2-diacylglycerol-lactones
43. Potent leads based on CA-19L, an anti-HIV active HIV-1 capsid fragment
44. Bivalent HIV-1 fusion inhibitors based on peptidomimetics
45. 環状ペプチドで標的細胞へターゲティングする
46. Exploratory studies on CA-15L, an anti-HIV active HIV-1 capsid fragment
47. Synthesis of hydrophilic caged DAG-lactones for chemical biology applications
48. Discovery and Development of Anti-HIV Therapeutic Agents: Progress Towards Improved HIV Medication
49. Development for Peptidomimetic Chemistry based on Chloroalkene Structures
50. Dimeric C34 Derivatives Linked through Disulfide Bridges as New HIV‐1 Fusion Inhibitors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.